Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by El-Tanani, M.
Right arrow Articles by Rudland, P. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by El-Tanani, M.
Right arrow Articles by Rudland, P. S.
[Cancer Research 61, 5619-5629, July 15, 2001]
© 2001 American Association for Cancer Research


Tumor Biology

Metastasis-inducing DNA Regulates the Expression of the Osteopontin Gene by Binding the Transcription Factor Tcf-41

Mohamed El-Tanani, Roger Barraclough, Mark C. Wilkinson and Philip S. Rudland2

Cancer and Polio Research Fund Laboratories, Life Sciences Building, School of Biological Sciences, University of Liverpool, Liverpool L69 3BX, United Kingdom

Small 1,000-bp fragments of genomic DNA obtained from human malignant breast cancer cell lines when transfected into a benign rat mammary cell line enhance transcription of the osteopontin gene and thereby cause the cells to metastasize in syngeneic rats. To identify the molecular events underlying this process, transient cotransfections of an osteopontin promoter-reporter construct and fragments of one metastasis-inducing DNA (Met-DNA) have identified the active components in the Met-DNA as the binding sites for the T-cell factor (Tcf) family of transcription factors. Incubation of cell extracts with active DNA fragments containing the sequence CAAAG caused retardation of their mobilities on polyacrylamide gels, and Western blotting identified Tcf-4, ß-catenin, and E-cadherin in the relevant DNA complexes in vitro. Transfection of an expression vector for Tcf-4 inhibited the stimulated activity of the osteopontin promoter-reporter construct caused by transiently transfected active fragments of Met-DNA or permanently transfected Met-DNA. This stimulated activity of the osteopontin promoter-reporter construct is accompanied by an increase in endogenous osteopontin mRNA but not in fos or actin mRNAs in the transfected cells. Permanent transfection of the benign rat mammary cell line with a 20-bp fragment from the Met-DNA containing the Tcf recognition sequence CAAAG caused an enhanced permanent production of endogenous osteopontin protein in vitro and induced the cells to metastasize in syngeneic rats in vivo. The corresponding fragment without the CAAAG sequence was without either effect. Therefore, the regulatory effect of the C9-Met-DNA is exerted, at least in part, by a CAAAG sequence that can sequester the endogenous inhibitory Tcf-4 and thereby promote transcription of osteopontin, the direct effector of metastasis in this system.




This article has been cited by other articles:


Home page
J. Virol.Home page
K. A. Whalen, G. F. Weber, T. L. Benjamin, and B. S. Schaffhausen
Polyomavirus Middle T Antigen Induces the Transcription of Osteopontin, a Gene Important for the Migration of Transformed Cells
J. Virol., May 15, 2008; 82(10): 4946 - 4954.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. K. Mason, S. McFarlane, P. G. Johnston, P. Crowe, P. J. Erwin, M. M. Domostoj, F. C. Campbell, S. Manaviazar, K. J. Hale, and M. El-Tanani
Agelastatin A: a novel inhibitor of osteopontin-mediated adhesion, invasion, and colony formation
Mol. Cancer Ther., March 1, 2008; 7(3): 548 - 558.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
C. D. Green, P. D. Thompson, P. G. Johnston, and M. K. El-Tanani
Interaction between Transcription Factor, Basal Transcription Factor 3, and the NH2-Terminal Domain of Human Estrogen Receptor {alpha}
Mol. Cancer Res., November 1, 2007; 5(11): 1191 - 1200.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Suzuki, E. Mose, C. Galloy, and D. Tarin
Osteopontin Gene Expression Determines Spontaneous Metastatic Performance of Orthotopic Human Breast Cancer Xenografts
Am. J. Pathol., August 1, 2007; 171(2): 682 - 692.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. K. El-Tanani, F. C. Campbell, P. Crowe, P. Erwin, D. P. Harkin, P. Pharoah, B. Ponder, and P. S. Rudland
BRCA1 Suppresses Osteopontin-mediated Breast Cancer
J. Biol. Chem., September 8, 2006; 281(36): 26587 - 26601.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
X. Chen, H. Xu, C. Wan, M. McCaigue, and G. Li
Bioreactor Expansion of Human Adult Bone Marrow-Derived Mesenchymal Stem Cells
Stem Cells, September 1, 2006; 24(9): 2052 - 2059.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Vietor, R. Kurzbauer, G. Brosch, and L. A. Huber
TIS7 Regulation of the {beta}-Catenin/Tcf-4 Target Gene Osteopontin (OPN) Is Histone Deacetylase-dependent
J. Biol. Chem., December 2, 2005; 280(48): 39795 - 39801.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Dihlmann, M. Kloor, C. Fallsehr, and M. von Knebel Doeberitz
Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells
Carcinogenesis, September 1, 2005; 26(9): 1503 - 1512.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Mi, H. Guo, P. Y. Wai, C. Gao, J. Wei, and P. C. Kuo
Differential Osteopontin Expression in Phenotypically Distinct Subclones of Murine Breast Cancer Cells Mediates Metastatic Behavior
J. Biol. Chem., November 5, 2004; 279(45): 46659 - 46667.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. El-Tanani, A. Platt-Higgins, P. S. Rudland, and F. C. Campbell
Ets Gene PEA3 Cooperates with {beta}-Catenin-Lef-1 and c-Jun in Regulation of Osteopontin Transcription
J. Biol. Chem., May 14, 2004; 279(20): 20794 - 20806.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. Zhang, B. He, and G. F. Weber
Growth Factor Signaling Induces Metastasis Genes in Transformed Cells: Molecular Connection between Akt Kinase and Osteopontin in Breast Cancer
Mol. Cell. Biol., September 15, 2003; 23(18): 6507 - 6519.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. S. Rudland, A. Platt-Higgins, M. El-Tanani, S. de Silva Rudland, R. Barraclough, J. H. R. Winstanley, R. Howitt, and C. R. West
Prognostic Significance of the Metastasis-associated Protein Osteopontin in Human Breast Cancer
Cancer Res., June 1, 2002; 62(12): 3417 - 3427.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. El-Tanani, D. G. Fernig, R. Barraclough, C. Green, and P. Rudland
Differential Modulation of Transcriptional Activity of Estrogen Receptors by Direct Protein-Protein Interactions with the T Cell Factor Family of Transcription Factors
J. Biol. Chem., November 2, 2001; 276(45): 41675 - 41682.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.